JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3601
PUT
Northrop Grumman
NOC
$67.6B
| $385K | ﹤0.01% |
1,500
| – | – |
2016 Q4
2 quarters
|
|
|
AFI
3602
DELISTED
Armstrong Flooring, Inc.
AFI
| $385K | ﹤0.01% |
21,403
+8,789
| +70% | +$165K |
2016 Q4
2 quarters
|
|
3603
iShares MSCI Ireland ETF
EIRL
$76.6M
| $384K | ﹤0.01% |
8,809
+180
| +2% | +$7.68K |
2013 Q2
16 quarters
|
|
3604
Liberty Latin America Class C
LILAK
$1.72B
| $384K | ﹤0.01% |
20,956
-497
| -2% | -$9.12K |
2015 Q3
7 quarters
|
|
|
FRAN
3605
DELISTED
Francesca's Holdings Corporation
FRAN
| $382K | ﹤0.01% |
2,914
-5,470
| -65% | -$887K |
2016 Q4
2 quarters
|
|
|
DOVA
3606
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $382K | ﹤0.01% |
+17,135
| New | +$361K |
2017 Q2
0 quarters
|
|
3607
Banco Santander
SAN
$202B
| $381K | ﹤0.01% |
59,379
-144,622
| -71% | -$898K |
2013 Q2
16 quarters
|
|
3608
State Street SPDR S&P Pharmaceuticals ETF
XPH
$509M
| $381K | ﹤0.01% |
8,851
-20,736
| -70% | -$874K |
2015 Q4
6 quarters
|
|
3609
ZTO Express
ZTO
$14.8B
| $381K | ﹤0.01% |
27,254
+26,692
| +4,749% | +$369K |
2016 Q4
2 quarters
|
|
3610
iShares California Muni Bond ETF
CMF
$4.8B
| $380K | ﹤0.01% |
6,458
-5,670
| -47% | -$333K |
2014 Q3
11 quarters
|
|
|
MCF
3611
DELISTED
Contango Oil & Gas Co.
MCF
| $380K | ﹤0.01% |
57,224
-5,132
| -8% | -$35.8K |
2013 Q2
16 quarters
|
|
|
ASRT
3612
DELISTED
Assertio
ASRT
| $379K | ﹤0.01% |
588
+14
| +2% | +$9.33K |
2015 Q4
6 quarters
|
|
|
JKS
3613
JinkoSolar
JKS
$482M
| $377K | ﹤0.01% |
+18,136
| New | +$327K |
2017 Q2
0 quarters
|
|
3614
Monro
MNRO
$426M
| $376K | ﹤0.01% |
9,029
-268,373
| -97% | -$13.4M |
2015 Q4
6 quarters
|
|
|
MDCO
3615
CALL
DELISTED
Medicines Co
MDCO
| $372K | ﹤0.01% |
9,800
| – | – |
2016 Q1
5 quarters
|
|
|
FFNW
3616
DELISTED
First Financial Northwest, Inc
FFNW
| $371K | ﹤0.01% |
22,991
-12,318
| -35% | -$199K |
2016 Q4
2 quarters
|
|
3617
Global Net Lease
GNL
$1.88B
| $368K | ﹤0.01% |
16,514
-18,228
| -52% | -$419K |
2016 Q4
2 quarters
|
|
3618
Otter Tail
OTTR
$3.71B
| $367K | ﹤0.01% |
9,276
-35,006
| -79% | -$1.38M |
2016 Q4
2 quarters
|
|
3619
ALPS O'Shares U.S. Quality Dividend ETF
OUSA
$715M
| $366K | ﹤0.01% |
12,532
+241
| +2% | +$7.03K |
2016 Q2
4 quarters
|
|
3620
Vanguard Russell 2000 ETF
VTWO
$16.6B
| $366K | ﹤0.01% |
6,490
-358
| -5% | -$19.9K |
2013 Q2
16 quarters
|
|
3621
ROBO Global Robotics & Automation Index ETF
ROBO
$2.1B
| $365K | ﹤0.01% |
+10,645
| New | +$359K |
2017 Q2
0 quarters
|
|
|
ECYT
3622
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $364K | ﹤0.01% |
242,466
-368,577
| -60% | -$791K |
2016 Q1
5 quarters
|
|
|
HBMD
3623
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $363K | ﹤0.01% |
+18,873
| New | +$356K |
2017 Q2
0 quarters
|
|
3624
uniQure
QURE
$1.58B
| $362K | ﹤0.01% |
58,481
+14,659
| +33% | +$79.2K |
2015 Q4
6 quarters
|
|
3625
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$293M
| $360K | ﹤0.01% |
9,666
-220
| -2% | -$8.26K |
2017 Q1
1 quarter
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.